<DOC>
	<DOCNO>NCT02045719</DOCNO>
	<brief_summary>Cat 's claw ( Uncaria tomentosa ) native amazonic plant exhibit anti-inflammatory antitumor property . Patients method : This prospective phase II study assess effect 100-mg dose dry extract U. tomentosa three time per day individual advance solid tumor , therapeutic option least 2 month life expectancy . In addition , several biochemical inflammatory parameter analyze .</brief_summary>
	<brief_title>Phase II Clinical Trial Uncaria Tomentosa ( Cat´s Claw ) Patients With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<criteria>individual advance solid tumor , therapeutic option least 2 moths life expectancy individual 18 year age old creatinine level twice upper limit normal ( ULN ) alanine ( ALT ) aspartate ( ASP ) transaminase level twice ULN direct bilirubin ( DB ) level 1.5 time ULN case preexist liver disease , ALT , ASP DB level could 2.5 time ULN pregnant breastfeed woman individual use chemotherapy tumortargeting antineoplastic treatment , except antalgic radiotherapy severe kidney liver failure know hypersensitiveness component medication use past history emotional disorder could interfere data collection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>cat´s claw</keyword>
	<keyword>uncaria tomentosa</keyword>
	<keyword>quality life</keyword>
	<keyword>therapeutic option</keyword>
</DOC>